Shashi Tharoor @ShashiTharoor
The Covaxin has not yet had Phase 3 trials. Approval was premature and could be dangerous. @drharshvardhan should please clarify. Its use should be avoided till full trials are over. India can start with the AstraZeneca vaccine in the meantime. — PolitiTweet.org
Citizen_Politics @CitizenPolitix_
@Jairam_Ramesh @drharshvardhan There is big lobby promoting this at cost of risking public health. Covaxin is not e… https://t.co/8fKY87kbLV